Speaker Rich Cleland is chief investigator of the consumer protection office at the FTC.
Launching a dietary supplement product? Need to know how to make health claims that meet the FTC’s muster? Then register for this webcast, taking place June 9.
Speaker Rich Cleland is chief investigator of the consumer protection office at the FTC. With nearly 30 years of experience as a government regulator, with most of that time looking at health claims, Cleland has investigated and prosecuted scores of cases against dietary supplement companies.
In this session, Cleland will discuss background research, experts, lawyers, study protocols, creating and updating substantiation files, and making sure that marketing is consistent with the science.
This webcast will raise questions that companies should be asking themselves through product development, testing, and marketing that will increase the likelihood that if someone does challenge your substantiation, it will meet that challenge.
Learn how to do it right.
This session is sponsored by the United Natural Products Alliance. Click here to register.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Continuing innovation in algae-DHA: 2024 Natural Products Expo West Report
March 26th 2024At this year’s Natural Products Expo West, two brands have launched their own versions of algae DHA ingredients; FrieslandCampina and Aker BioMarine. Each brand showcased a different approach to the ingredient.
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.